Clinical Trials Browser

Completed × Triple Negative Breast Neoplasms × ruxolitinib × Clear all

NCT03012230 2024-01-31

Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer

Phase 1 Completed

Triple Negative Breast Neoplasms